Sanofi Set To Seek $442 Million From Apotex For Plavix Infringement
District court denies Apotex's request to stay the award of damages; Patent Office reexamination finds Plavix patent is valid.
District court denies Apotex's request to stay the award of damages; Patent Office reexamination finds Plavix patent is valid.